Pay in 4 interest-free payments of $5.21 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Despite their high efficacy, these drugs are associated with high costs and ongoing supply shortages, limiting access for many patients
Published phase 2 obesity research evaluated once-weekly dose groups, including 1 mg, 4 mg, 8 mg, and 12 mg targets
Whilst prescription GLP-1 medications are rigorously tested and regulated by the MHRA, probiotic supplements fall under food supplement regulations with less stringent evidence requirements
Diabetologia (2012) 55:256582
(85 g) provides 93% of the DV (22,27)
Retatrutide is an investigational triple agonist targeting GLP-1, GIP, and glucagon receptors
US$ 22.49
US$ 29.44
US$ 21.19
US$ 28.56
